LINC00887 and central nervous system cancer: These results are consistent with previous studies in which LINC00887 was also upregulated and its knockdown suppressed cell proliferation, migration and invasion in several tumors, including renal cell carcinoma [20,21,22], nasopharyngeal carcinoma [23], glioma [24], lung carcinoma [25] and tongue squamous carcinoma [26].